Zdársky, B., Edtmayer, S., Witalisz-Siepracka, A., Weiss, S., Boigenzahn, S., Heindl, K., Zahma, S., Győrffy, B., Moriggl, R., & Stoiber, D. (2025). Loss of STAT3 in Acute Myeloid Leukemia Favors Tissue Infiltration Linked to CXCR4 Signaling. Blood Neoplasia, 2(4), 100158.

Costanza, M., Giordano, C., von Brünneck, A., Zhao, J., Makky, A., Vinh, K., Montes-Mojarro, I. A., Reisinger, F., Forchhammer, S., Witalisz-Siepracka, A., Edtmayer, S., Stoiber, D., Yin, G., Horst, D., Fischer, A., Siebert, R., Nicolay, J. P., Yin, M., Janz, M., Fend, F., Becker, J. C., Schürch, C. M., Kenner, L., Assaf, C., Merkel, O., & Mathas, S. (2025). Preclinical in vitro and in vivo evidence for CD74-targeting as effective treatment strategy for cutaneous T cell lymphomas. British Journal of Dermatology, 192(5), 883-895.

Weiss, S., Zdársky, B., Witalisz-Siepracka, A., Edtmayer, S., Holzer, A., Heindl, K., Casanova, E., Podar, K., & Stoiber, D. (2025). Atovaquone and selinexor as a novel combination treatment option in acute myeloid leukemia. Cancer Letters, 613, 217501.

Stoiber, D. (2024). The STAT3/ICAM-1 axis in AML facilitates NK cell-mediated surveillance.